FDA approves Nemluvio for moderate-to-severe atopic dermatitis
FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s
Updated on: January 06,2025
0
FDA approves Nemluvio for moderate-to-severe atopic dermatitis
FDA approves Nemluvio for moderate-to-severe atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-s
Updated on:January 06,2025
0
